---
title: "Pre-market hot trades in US stocks: Processa Pharmaceuticals up 15.52% in pre-market; Greenlane down 12.22% in pre-market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281764358.md"
description: "Processa Pharmaceuticals pre-market up 15.52%; Greenlane pre-market down 12.22%; Profusa pre-market up 146.70%; Focus Media pre-market up 123.92%; iRobot pre-market up 78.96%"
datetime: "2026-04-06T13:17:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281764358.md)
  - [en](https://longbridge.com/en/news/281764358.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281764358.md)
---

# Pre-market hot trades in US stocks: Processa Pharmaceuticals up 15.52% in pre-market; Greenlane down 12.22% in pre-market

**Hot Pre-Market Trades in US Stocks**

Processa Pharmaceuticals is up 15.52% in pre-market trading. Based on recent key news:

1.  On April 2, James Neal, a director of Processa Pharmaceuticals, purchased 789 shares of common stock at a price of $2.54 per share. This move increased Neal's direct holdings to 818 shares. This insider purchase is seen as a vote of confidence in the company's future, driving the stock price up. Source: EDGAR system discloses significant recent fluctuations in the US stock market, investors should exercise caution.

Greenlane is down 12.22% in pre-market trading, with no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

**Top Gainers in Pre-Market Trading in US Stocks**

Profusa is up 146.70% in pre-market trading. Based on recent key news:

1.  On April 6, Profusa announced the signing of a letter of intent to acquire BioInsights' PanOmics molecular diagnostics platform, with a transaction amount of approximately $30 million in an all-stock deal. This move grants Profusa exclusive rights to the technology and plans to apply it in the field of pancreatic cancer, significantly boosting the stock price. Source: Reuters
    
2.  On April 6, Profusa expanded its collaboration with the Mayo Clinic to utilize the new platform to monitor patients undergoing pancreatic surgery, enhancing the company's position in the precision diagnostics market and further boosting market confidence. Source: Benzinga
    
3.  On April 6, Profusa amended its financing agreement to issue $555,555.55 of 12% senior secured convertible notes to increase working capital and support business expansion, driving the stock price up. Source: SEC announcement on the expansion of the precision diagnostics market, collaboration enhances potential.
    

Focus Media is up 123.92% in pre-market trading. There is no significant news recently; the trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no\_news

iRobot is up 78.96% in pre-market trading, with no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation

### Related Stocks

- [PCSA.US](https://longbridge.com/en/quote/PCSA.US.md)
- [GNLN.US](https://longbridge.com/en/quote/GNLN.US.md)

## Related News & Research

- [Moneycontrol Pro Panorama | Is the gold theme set to unwind?](https://longbridge.com/en/news/289436945.md)
- [These 10 Stocks Are Getting Crushed By Short Sellers Right Now](https://longbridge.com/en/news/289521552.md)
- [Greif (GEF) Is Up 7.5% After Dividend Hike And Packaging Price Increases Has The Bull Case Changed?](https://longbridge.com/en/news/289650722.md)
- [As Remaining Performance Obligation Swells, Oracle Stock Is Positioned for Growth Acceleration](https://longbridge.com/en/news/289627686.md)
- [Rockford Fosgate Introduces New PUNCH® PRO Speakers | PATK Stock News](https://longbridge.com/en/news/289626073.md)